This website uses cookies. For more information please contact us or consult our privacy policy.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Covington Advises Procter & Gamble on $3.1B Sale of Global Pharmaceuticals Business to Warner Chilcott

8/24/2009

NEW YORK, NY, August 24, 2009 — Procter & Gamble today announced the sale of its global pharmaceuticals business to Warner Chilcott Ltd. Covington & Burling LLP advised Procter & Gamble on the transaction.

Procter & Gamble is a leading global branded products company, with one of the strongest portfolios of quality, leadership brands in consumer health and wellness, as well as trusted consumer brands, including many household names. Warner Chilcott is an international pharmaceutical company specializing in women’s healthcare and dermatology.

The Covington team worked closely with the Procter & Gamble in-house legal team and was led by partners Scott Smith and Andrew Ment, both based in the firm’s New York office. The Procter & Gamble legal team was led by transaction specialists Joseph Stegbauer and Mary Pat McMahon.

Covington’s global team was also comprised of associates Jonathan Jacobs and Nina McIntyre (corporate, New York), partner Andrea Reister (patents, Washington), partner Scott Cunningham (US regulatory, Washington), partner Grant Castle and associate Joanna Wheeler (EU regulatory, London), of counsel Genevieve Michaux (EU regulatory, Brussels), partner Corinne Goldstein (environmental, Washington), partner Albert Wells and associate Lisa Schwartz (IT, New York), partner Michael Francese (employee benefits, Washington), and of counsel Peter Cooke (employment, London).

The P&G legal team also included Chris Walther (General Counsel, Western Europe), Matt Malloy (General Counsel, Pharmaceuticals), Kelly McDow (patents), Veronique Huysmans and Gunda Niehaus (European corporate).

Share this article: